TAEK-VAC-HerBy Vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TAEK-VAC-HerBy Vaccine, covering 2025-03-03 to 2025-03-03. Get the full timeline:
Most recent: Clinical Trial Update: TAEK-VAC-HerBy Vaccine for Brachyury and HER2 Expressing Cancer [Phase 1]